Establishment of a Mouse Model for Human Rhinovirus Infection

References

1. Eggers H. J. 1976; Successful treatment of enterovirus-infected mice by 2-(α-hydroxylbenzyl)-benzimidazole and guanidine. Journal of Experimental Medicine 143:1367–1381
   [Google Scholar]
2. Gwaltney J. M. Jr 1983; Rhinovirus colds: epidemiology, clinical characteristics and transmission. European Journal of Respiratory Disease 64, (supplement 128):336–339
   [Google Scholar]
3. Herrmann E. C. Jr, Herrmann J. A., Delong D. C. 1982; Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles. Antiviral Research 2:339–346
   [Google Scholar]
4. Madshus I. H., Olsnes S., Sandvig K. 1984; Different pH requirements for entry of the two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus. Virology 139:346–357
   [Google Scholar]
5. Shipkowitz N. L., Bower R. R., Schleicher J. B., Aquino F., Appell R. N., Roderick W. R. 1972; Antiviral activity of a bis-benzimidazole against experimental rhinovirus infections in chimpanzees. Applied Microbiology 23:117–122
   [Google Scholar]
6. Tyrrell D. A. J., Bynoe M. L. 1966; Cultivation of viruses from a high proportion of patients with colds. Lancet i:76–77
   [Google Scholar]
7. Wilson J. N., Cooper P. D. 1963; Aspects of the growth of poliovirus as revealed by the photodynamic effects of neutral red and acridine orange. Virology 21:135–145
   [Google Scholar]
8. Yin F. H., Lomax N. B. 1983; Host range mutants of human rhinovirus in which nonstructural proteins are altered. Journal of Virology 48:410–418
   [Google Scholar]